Riskpilot← Back to searchSign inGet full accessØRSTA SPECSAVERS AS
ASActiveOrg 925937215Vikegata 17, 6150 ØrstaRetail sale of medical and orthopaedic goods · NACE 4774Est. 20207 employees
Revenue 2025
NOK 8,4M
+5% vs 2024
EBITDA margin
5.5%
-4% vs 2024
Equity ratio
-49.4%
Financial strength
Net profit 2025
NOK -354K
-6% vs 2024
| Revenue | NOK 8,4M | +5% |
| EBITDA | NOK 460K | -4% |
| Net profit | NOK -354K | -6% |
| Total assets | NOK 2,4M | -23% |
| Equity | NOK -1,2M | -42% |
| Employees | 7 | — |
Legal name
ØRSTA SPECSAVERS AS
Org number
925937215
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9. november 2020
Share capital
NOK 30 125
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Company purpose
Salg av optiske varer og tjenester.
Address
Vikegata 17, 6150 Ørsta
Phone
+4740000544
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 6 277 | 8 020 | 8 418 |
| Staff expenses | −0 | −2 764 | −2 929 | −3 120 |
| EBITDA | −3 | −20 | 479 | 460 |
| Depreciation & amort. | −0 | −448 | −726 | −726 |
| EBIT | −3 | −468 | −247 | −266 |
| Net financials | 0 | −68 | −88 | −87 |
| Profit before tax | −3 | −536 | −335 | −354 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −3 | −536 | −335 | −354 |
| Item | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 27 | 3 646 | 3 154 | 2 436 |
| Equity | 21 | −515 | −850 | −1 203 |
| Long-term debt | 0 | 3 305 | 2 787 | 2 250 |
| Short-term debt | 6 | 856 | 1 217 | 1 389 |
| Total debt | 6 | 4 161 | 4 004 | 3 640 |
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
20212025
Equity ratio
-49.4%
This company
38.2%
Market median
-229% vs market
20212025
Return on equity
-35360700.0%
This company
18.4%
Market median
-192177817% vs market
20212025
Net profit margin
-4.2%
This company
8.1%
Market median
-152% vs market
20212025
Asset turnover
3.46×
This company
1.12×
Market median
+209% vs market
20212025
Debt / equity
3.02×
This company
0.62×
Market median
-387% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2023-02-28
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-09-23 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NH Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
JB Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
AE Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2022 – 2023 | |
| Chairman | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.21% | 50.21% | 2022 | |
Norway Specsavers Ltd | Company | 50.21% | 50.21% | 2024 |
| Company | 49.79% | 49.79% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØRSTA SPECSAVERS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Helen Kleppe | Chief Executive Officer | 0 companies |
| Jan-Kristian Bjerke | Chief Executive Officer | 0 companies |
| Anne-Marit Eliassen | Chief Executive Officer | 0 companies |
| Richard Neil Owens | Chairman | 0 companies |
| Henning Jørgen Eriksen | Chairman | 0 companies |
| Jan Kristian Bjerke | Chairman | 0 companies |
| Henning Jørgen Eriksen Færden | Board of Directors | 0 companies |